中文 | English
Return
Total: 449 , 1/45
Show Home Prev Next End page: GO
Author:( Xuejun LI)

1.Regulation of chromosome regulator EZH2 in cancer epigenetics and EZH2 targeted drugs in cancer therapy

Xin LI ; Xuejun LI

Chinese Journal of Pharmacology and Toxicology 2016;30(12):1273-1281

2.Chemical proteomics and discovery of drug targets.

Hongqin YANG ; Xuejun LI

Acta Pharmaceutica Sinica 2011;46(8):877-82

3.Drug targets discovery based on dynamic signal transduction networks.

Juan WANG ; Xuejun LI

Acta Pharmaceutica Sinica 2010;45(1):1-8

4.Progress of Early Diagnosis in Primary Carcinoma of Gallbladder

Shoushuai LI ; Xuejun SUN

Chinese Journal of Bases and Clinics in General Surgery 2003;0(04):-

5.Hydroxyl radical and cerebral ischemia

Xuejun LI ; Fengyan SUN

Chinese Pharmacological Bulletin 1998;0(S1):-

6.Analysis of the Indication for 949 Sesarean Section

Xuejun LI ; Yanqin HE

Journal of Chinese Physician 2002;0(S1):-

7.Amplification of 160 000 Bullous Pemphigoid Antigen cDNA Fragment from Human Keratinocyte Library

Guanqun LI ; Xuejun ZHU

Chinese Journal of Dermatology 1995;0(03):-

8.Detection of HPV DNA in Condylomata Acuminata by Direct in Situ PCR

Hui LI ; Xuejun ZHU

Chinese Journal of Dermatology 1995;0(03):-

9.Effects of Panax notoginseng saponin on macrophage inflammatory protein-1? and monocyte chemoattractant protein-1 in plasma in rats with pulmonary fibrosis

Xuejun LI ; Shehuai CUI ;

Journal of Third Military Medical University 1988;0(06):-

10.Analysis of 15 case with Bartter syndrome and literature review

Xuejun YANG ; Qiu LI

Journal of Clinical Pediatrics 2014;(8):785-788

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 449 , 1/45 Show Home Prev Next End page: GO